E
Rallybio Corporation RLYB
$0.626 $0.0325.39% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 43.62% 36.83% 22.52% 5.04% -4.76%
Total Depreciation and Amortization -18.31% -15.07% -12.67% -10.46% -10.13%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -9.67% -8.00% -12.68% -3.88% -0.91%
Change in Net Operating Assets -184.82% -147.15% -106.03% 329.85% 989.61%
Cash from Operations 22.23% 22.70% 18.22% 20.07% 13.13%
Capital Expenditure -- -- -- -- -200.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 5.77% -5.92% 21.04% 361.28% 291.09%
Cash from Investing 5.81% -5.89% 21.09% 361.22% 290.98%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.49% 1,838.65% 1,838.65% -89.37% -89.38%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 95.74% -- -92.81% 63.20% 68.95%
Cash from Financing -99.68% 1,743.62% 3,535.66% -89.75% -89.71%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 54.52% 77.63% 67.38% 118.93% 43.65%